JP2016515215A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016515215A5 JP2016515215A5 JP2016502124A JP2016502124A JP2016515215A5 JP 2016515215 A5 JP2016515215 A5 JP 2016515215A5 JP 2016502124 A JP2016502124 A JP 2016502124A JP 2016502124 A JP2016502124 A JP 2016502124A JP 2016515215 A5 JP2016515215 A5 JP 2016515215A5
- Authority
- JP
- Japan
- Prior art keywords
- hla
- antibody
- donor
- beads
- biological sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 16
- 239000011324 bead Substances 0.000 claims 7
- 239000012472 biological sample Substances 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 2
- 238000002965 ELISA Methods 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 230000003053 immunization Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000000523 sample Substances 0.000 claims 2
- 229920000936 Agarose Polymers 0.000 claims 1
- 102000016911 Deoxyribonucleases Human genes 0.000 claims 1
- 108010053770 Deoxyribonucleases Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 claims 1
- 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 claims 1
- 102100028971 HLA class I histocompatibility antigen, C alpha chain Human genes 0.000 claims 1
- 102100040482 HLA class II histocompatibility antigen, DR beta 3 chain Human genes 0.000 claims 1
- 102100028636 HLA class II histocompatibility antigen, DR beta 4 chain Human genes 0.000 claims 1
- 102100028640 HLA class II histocompatibility antigen, DR beta 5 chain Human genes 0.000 claims 1
- 102100040485 HLA class II histocompatibility antigen, DRB1 beta chain Human genes 0.000 claims 1
- 108010075704 HLA-A Antigens Proteins 0.000 claims 1
- 108010058607 HLA-B Antigens Proteins 0.000 claims 1
- 108010052199 HLA-C Antigens Proteins 0.000 claims 1
- 108010010378 HLA-DP Antigens Proteins 0.000 claims 1
- 102000015789 HLA-DP Antigens Human genes 0.000 claims 1
- 108010062347 HLA-DQ Antigens Proteins 0.000 claims 1
- 108010039343 HLA-DRB1 Chains Proteins 0.000 claims 1
- -1 HLA-DRB2 Proteins 0.000 claims 1
- 108010061311 HLA-DRB3 Chains Proteins 0.000 claims 1
- 108010040960 HLA-DRB4 Chains Proteins 0.000 claims 1
- 108010016996 HLA-DRB5 Chains Proteins 0.000 claims 1
- 101710160107 Outer membrane protein A Proteins 0.000 claims 1
- 239000004793 Polystyrene Substances 0.000 claims 1
- 239000000370 acceptor Substances 0.000 claims 1
- 229960002685 biotin Drugs 0.000 claims 1
- 235000020958 biotin Nutrition 0.000 claims 1
- 239000011616 biotin Substances 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 230000009089 cytolysis Effects 0.000 claims 1
- 239000003599 detergent Substances 0.000 claims 1
- 239000000975 dye Substances 0.000 claims 1
- 239000007850 fluorescent dye Substances 0.000 claims 1
- 239000004816 latex Substances 0.000 claims 1
- 229920000126 latex Polymers 0.000 claims 1
- 239000012139 lysis buffer Substances 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 229920002223 polystyrene Polymers 0.000 claims 1
- 239000000700 radioactive tracer Substances 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361782003P | 2013-03-14 | 2013-03-14 | |
| US61/782,003 | 2013-03-14 | ||
| PCT/US2014/026406 WO2014151763A1 (en) | 2013-03-14 | 2014-03-13 | Methods of detecting donor-specific antibodies and systems for practicing the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016515215A JP2016515215A (ja) | 2016-05-26 |
| JP2016515215A5 true JP2016515215A5 (enExample) | 2017-04-13 |
| JP6548631B2 JP6548631B2 (ja) | 2019-07-24 |
Family
ID=51581037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502124A Active JP6548631B2 (ja) | 2013-03-14 | 2014-03-13 | ドナー特異的抗体を検出する方法及び該方法を実施するためのシステム |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US10101337B2 (enExample) |
| EP (2) | EP3435080A1 (enExample) |
| JP (1) | JP6548631B2 (enExample) |
| CN (1) | CN105308457B (enExample) |
| AU (1) | AU2014236882B2 (enExample) |
| BR (1) | BR112015022844B1 (enExample) |
| CA (1) | CA2905954C (enExample) |
| WO (1) | WO2014151763A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009322607B2 (en) | 2008-12-01 | 2015-05-14 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for detection of complement fixing antibodies |
| BR112015022844B1 (pt) | 2013-03-14 | 2023-01-24 | The Board Of Trustees Of The Leland Stanford Junior University | Método para determinar a presença ou ausência de anticorpos específicos do doador em uma amostra biológica, sistema e kit para praticar o mesmo |
| US10527613B2 (en) | 2015-11-10 | 2020-01-07 | The Board Of Trustees Of The Leland Stanford Junior University | Biomarker detection methods and systems and kits for practicing same |
| WO2018039637A1 (en) * | 2016-08-26 | 2018-03-01 | Juno Therapeutics, Inc. | Methods of enumerating particles present in a cell composition |
| JP6952295B2 (ja) * | 2016-09-09 | 2021-10-20 | 国立大学法人金沢大学 | ヒト抗ｈｌａモノクローナル抗体の作製方法 |
| EP3674712A1 (en) * | 2017-01-18 | 2020-07-01 | Essen Instruments, Inc. D/B/A Essen BioScience, Inc. | Methods and reagents for determining immunoglobulin gamma (igg) antibody isotype concentration from biological samples |
| CN111398580B (zh) * | 2017-11-03 | 2023-06-13 | 科美诊断技术股份有限公司 | 一种检测样本中目标IgM抗体的方法 |
| WO2019169194A1 (en) | 2018-02-28 | 2019-09-06 | Juno Therapeutics, Inc. | Methods for detecting particles present in a cell composition |
| JP7502805B2 (ja) * | 2019-03-21 | 2024-06-19 | ザ ユーエイビー リサーチ ファウンデイション | 補体媒介性溶解に対する細胞感受性を増加させる方法 |
| CA3136684A1 (en) * | 2019-05-06 | 2020-11-12 | The Regents Of The University Of California | Non-hla markers of transplant rejection |
| CN111257566B (zh) * | 2020-01-22 | 2023-03-24 | 苏州才博医学科技有限公司 | 用于检测同种异体的、或供者特异性的非hla抗体的方法 |
| CN111413505B (zh) * | 2020-04-08 | 2023-03-24 | 苏州才博医学科技有限公司 | 全面检测非hla类供者特异性抗体的细胞学方法 |
| CN112924696A (zh) * | 2021-01-27 | 2021-06-08 | 浙江大学 | 一种检测人绒毛滋养细胞外泌体hla-e水平评估母胎免疫耐受的方法 |
| CN114019154A (zh) * | 2021-11-09 | 2022-02-08 | 河北博因生物科技有限公司 | 基于流式细胞术用于补体检测的试剂盒及制备方法和应用 |
| CN115125251B (zh) * | 2022-08-22 | 2023-11-03 | 广东忠信生物科技有限公司 | 一种高效获得特异性全人单克隆抗体基因的方法和应用 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS501571A (enExample) | 1973-08-28 | 1975-01-09 | ||
| US4708871A (en) | 1983-03-08 | 1987-11-24 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| JPS6184560A (ja) | 1984-10-02 | 1986-04-30 | Karupisu Shokuhin Kogyo Kk | 補体結合性抗体の測定法 |
| US5035995A (en) | 1984-10-02 | 1991-07-30 | Calpis Food Industry Co., Ltd. | Test method involving substance-conjugated complement component C1q |
| JPS61245060A (ja) | 1985-04-23 | 1986-10-31 | Takara Shuzo Co Ltd | ヒト補体１ｑ定量用キツト及び定量法 |
| EP0204522A3 (en) | 1985-05-30 | 1987-09-16 | Genetic Systems Corporation | Monoclonal antibody panel for histocompatibility typing |
| IL84160A0 (en) | 1986-10-16 | 1988-03-31 | Vasocor | Method and kit for immune complex assay |
| US5176998A (en) * | 1986-12-01 | 1993-01-05 | The Scripps Research Institute | Cell surface antigen detection method |
| DE69132273D1 (de) | 1990-10-10 | 2000-08-03 | Univ Maryland | Verfahren und vorrichtung zur bestimmung von lebensdauer von fluoreszenz in der durchflusscytometrie |
| US5223397A (en) | 1991-06-05 | 1993-06-29 | Sangstat Medical Corporation | Soluble hla cross-match |
| US5270169A (en) | 1992-06-23 | 1993-12-14 | Sangstat Medical Corporation | Detection of HLA antigen-containing immune complexes |
| ATE348175T1 (de) | 1992-07-17 | 2007-01-15 | Dana Farber Cancer Inst Inc | Method eder intrazellularen bindung von zielgerichteten molekülen |
| US5851829A (en) | 1993-07-16 | 1998-12-22 | Dana-Farber Cancer Institute | Method of intracellular binding of target molecules |
| GB9502112D0 (en) | 1995-02-03 | 1995-03-22 | British Biocell Int | Assay device and method |
| US6159748A (en) | 1995-03-13 | 2000-12-12 | Affinitech, Ltd | Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry |
| US5948627A (en) | 1997-05-30 | 1999-09-07 | One Lambda | Immunobead flow cytometric detection of anti-HLA panel-reactive antibody |
| NZ516848A (en) | 1997-06-20 | 2004-03-26 | Ciphergen Biosystems Inc | Retentate chromatography apparatus with applications in biology and medicine |
| CA2307166A1 (en) | 1997-10-31 | 1999-05-14 | Genentech, Inc. | Methods and compositions comprising glycoprotein glycoforms |
| US6682940B2 (en) | 1999-05-04 | 2004-01-27 | Dan A. Pankowsky | Products and methods for single parameter and multiparameter phenotyping of cells |
| WO2003020904A2 (en) | 2001-08-31 | 2003-03-13 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Methods of generating human cd4+ th1 cells |
| CN1423130A (zh) | 2002-04-26 | 2003-06-11 | 帕弗瑞生物技术(北京)有限公司 | 流式测定固定补体抗体的hla交叉配型方法和试剂盒 |
| CN1444044A (zh) | 2002-06-18 | 2003-09-24 | 帕弗瑞生物技术(北京)有限公司 | 以酶联免疫测定为基础的hla补体依赖性细胞毒性抗体检测方法和试剂盒 |
| TW200508609A (en) * | 2003-07-15 | 2005-03-01 | Bioarray Solutions Ltd | Detection of cell membrane-associated proteins using membrane fragments displayed on encoded microparticle arrays |
| US20050277158A1 (en) * | 2004-06-10 | 2005-12-15 | Ge Chen | Method and kit for donor specific complement-fixing antibodies crossmatch |
| US7799556B2 (en) | 2004-06-17 | 2010-09-21 | George Dacai Liu | System and method for antigen structure-independent detection of antigens captured on antibody arrays |
| CA2606916A1 (en) | 2005-05-06 | 2006-11-16 | Platypus Technologies, Llc | Liquid crystal based analyte detection |
| CN100354629C (zh) | 2005-10-17 | 2007-12-12 | 中国人民解放军第三军医大学第一附属医院 | 用胶体金标记补体第一成分q亚单位做指示剂的蛋白芯片/微阵列检测系统及检测方法 |
| WO2008060713A2 (en) | 2006-06-22 | 2008-05-22 | Massachusetts Institute Of Technology | Flow cytometry methods and immunodiagnostics with mass sensitive readout |
| GB0618496D0 (en) | 2006-09-20 | 2006-11-01 | Common Services Agency | Blood typing |
| JP2008100986A (ja) | 2006-09-21 | 2008-05-01 | Takahiro Ochi | Ｃ１ｑ結合物質、ならびにその使用 |
| NZ579010A (en) | 2007-02-20 | 2012-03-30 | Anaptysbio Inc | Somatic hypermutation systems |
| US7964350B1 (en) * | 2007-05-18 | 2011-06-21 | Applied Biosystems, Llc | Sample preparation for in situ nucleic acid analysis |
| JP2009080019A (ja) * | 2007-09-26 | 2009-04-16 | Nippon Sekijiyuujishiya | 蛍光ビーズを用いた免疫複合体検出による抗体解析法 |
| DE102008045696A1 (de) | 2008-09-04 | 2010-03-11 | Drk Blutspendedienst West Ggmbh | Granulozyten HNA-3a/b-Antigen |
| AU2009322607B2 (en) * | 2008-12-01 | 2015-05-14 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for detection of complement fixing antibodies |
| WO2010138456A2 (en) | 2009-05-29 | 2010-12-02 | The Regents Of The University Of California | B cell signature associated with tolerance in transplant recipients |
| US9637719B2 (en) | 2013-12-06 | 2017-05-02 | Douglas T. Gjerde | Devices and methods for purification of biological cells |
| US20120065092A1 (en) | 2010-09-14 | 2012-03-15 | Wai Hobert | Fusion analyte cytometric bead assay, and systems and kits for performing the same |
| AU2012304181C1 (en) | 2011-08-30 | 2017-04-27 | The Governors Of The University Of Alberta | Method and system for ABO antibody detection and characterization |
| US20160041185A1 (en) | 2013-03-14 | 2016-02-11 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of Detecting Complement Fixing and Non-Complement Fixing Antibodies and Systems for Practicing the Same |
| BR112015022844B1 (pt) | 2013-03-14 | 2023-01-24 | The Board Of Trustees Of The Leland Stanford Junior University | Método para determinar a presença ou ausência de anticorpos específicos do doador em uma amostra biológica, sistema e kit para praticar o mesmo |
| CN105229032A (zh) | 2013-03-18 | 2016-01-06 | 比奥塞罗克斯产品公司 | 人源化抗cd134(ox40)抗体及其应用 |
| CN106574925B (zh) | 2014-05-23 | 2019-07-26 | 萤火虫生物股份有限公司 | 用于生物测定的底物介导的反应器 |
| MA41414A (fr) | 2015-01-28 | 2017-12-05 | Centre Nat Rech Scient | Protéines de liaison agonistes d' icos |
| WO2017011316A1 (en) | 2015-07-10 | 2017-01-19 | The Trustees Of The University Of Pennsylvania | Treatment of a canine cd20 positive disease or condition using a canine cd20-specific chimeric antigen receptor |
| US10527613B2 (en) | 2015-11-10 | 2020-01-07 | The Board Of Trustees Of The Leland Stanford Junior University | Biomarker detection methods and systems and kits for practicing same |
-
2014
- 2014-03-13 BR BR112015022844-5A patent/BR112015022844B1/pt active IP Right Grant
- 2014-03-13 EP EP18182248.7A patent/EP3435080A1/en not_active Withdrawn
- 2014-03-13 AU AU2014236882A patent/AU2014236882B2/en active Active
- 2014-03-13 EP EP14770220.3A patent/EP2972348B1/en active Active
- 2014-03-13 JP JP2016502124A patent/JP6548631B2/ja active Active
- 2014-03-13 CN CN201480026715.2A patent/CN105308457B/zh active Active
- 2014-03-13 CA CA2905954A patent/CA2905954C/en active Active
- 2014-03-13 WO PCT/US2014/026406 patent/WO2014151763A1/en not_active Ceased
- 2014-03-13 US US14/775,150 patent/US10101337B2/en active Active
-
2018
- 2018-08-22 US US16/109,481 patent/US10746744B2/en active Active
-
2020
- 2020-08-17 US US16/995,614 patent/US11796547B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016515215A5 (enExample) | ||
| Lee et al. | Estimating the neutralizing effect and titer correlation of semi-quantitative anti-SARS-CoV-2 antibody immunoassays | |
| HRP20201856T1 (hr) | Antitijela koja se vežu za ljudski ligand i programiranje smrti (pd-l1) | |
| Ellis | Interpretation of HLA single antigen bead assays | |
| CN105004862B (zh) | 一种高通量联合检测丙肝病毒抗原抗体的试剂 | |
| BR112013010213A2 (pt) | anticorpos que unem ligantes solúveis de receptores de célula t | |
| BR112015022844A2 (pt) | métodos para detecção de anticorpos para doadores específicos e sistemas para pratica destes | |
| Fu et al. | The utility of specific antibodies against SARS-CoV-2 in laboratory diagnosis | |
| Duquesnoy et al. | Detection of antibodies against HLA-C epitopes in patients with rejected kidney transplants | |
| JP2013072663A5 (enExample) | ||
| ATE466108T1 (de) | Optoelektronisches detektionssystem | |
| JP2017026631A5 (enExample) | ||
| Otis et al. | Heparin‐induced thrombocytopenia: current status and diagnostic challenges | |
| Jalali et al. | Aptamer based diagnosis of crimean-congo hemorrhagic fever from clinical specimens | |
| RU2015104737A (ru) | Способ обнаружения мультиспецифического связывающего агента | |
| JP2018527895A5 (enExample) | ||
| Siev et al. | Correlation between serum and plasma antibody titers to mycobacterial antigens | |
| Chou et al. | The detection of the HLA-B27 antigen by immunomagnetic separation and enzyme-linked immunosorbent assay—comparison with a flow cytometric procedure | |
| CA2742804C (en) | Fluorescent neutralization and adherence inhibition assays | |
| Martel et al. | Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population | |
| Yang et al. | Clinical diagnostic performance of light‐initiated chemiluminescent assay compared with the Architect chemiluminescence immunoassay for detection of HCV antibody | |
| WO2011003598A3 (de) | Detektion von antigenen | |
| Echevarría et al. | Sensitivity of a modified version of the ARCHITECT® Anti-HCV test in detecting samples with immunoblot-confirmed, low-level antibody to hepatitis C virus | |
| Meyer et al. | A novel antigen‐specific capture assay for the detection of platelet antibodies and HPA‐1a phenotyping | |
| Rosser et al. | Approaches for the characterization of clinically relevant pre‐transplant human leucocyte antigen (HLA) antibodies in solid organ transplant patients |